152 related articles for article (PubMed ID: 32689795)
1. Selective Peptidomimetic Inhibitors of NTMT1/2: Rational Design, Synthesis, Characterization, and Crystallographic Studies.
Mackie BD; Chen D; Dong G; Dong C; Parker H; Schaner Tooley CE; Noinaj N; Min J; Huang R
J Med Chem; 2020 Sep; 63(17):9512-9522. PubMed ID: 32689795
[TBL] [Abstract][Full Text] [Related]
2. Improved Cell-Potent and Selective Peptidomimetic Inhibitors of Protein N-Terminal Methyltransferase 1.
Dong G; Iyamu ID; Vilseck JZ; Chen D; Huang R
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209173
[TBL] [Abstract][Full Text] [Related]
3. Structure-based Discovery of Cell-Potent Peptidomimetic Inhibitors for Protein N-Terminal Methyltransferase 1.
Chen D; Dong G; Deng Y; Noinaj N; Huang R
ACS Med Chem Lett; 2021 Mar; 12(3):485-493. PubMed ID: 33738076
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Bisubstrate Inhibitors for Protein N-Terminal Methyltransferase 1.
Chen D; Dong G; Noinaj N; Huang R
J Med Chem; 2019 Apr; 62(7):3773-3779. PubMed ID: 30883119
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and kinetic analysis of potent protein N-terminal methyltransferase 1 inhibitors.
Zhang G; Richardson SL; Mao Y; Huang R
Org Biomol Chem; 2015 Apr; 13(14):4149-54. PubMed ID: 25712161
[TBL] [Abstract][Full Text] [Related]
6. Probing the Plasticity in the Active Site of Protein N-terminal Methyltransferase 1 Using Bisubstrate Analogues.
Chen D; Dong C; Dong G; Srinivasan K; Min J; Noinaj N; Huang R
J Med Chem; 2020 Aug; 63(15):8419-8431. PubMed ID: 32605369
[TBL] [Abstract][Full Text] [Related]
7. Chemoproteomic Study Uncovers HemK2/KMT9 As a New Target for NTMT1 Bisubstrate Inhibitors.
Chen D; Meng Y; Yu D; Noinaj N; Cheng X; Huang R
ACS Chem Biol; 2021 Jul; 16(7):1234-1242. PubMed ID: 34192867
[TBL] [Abstract][Full Text] [Related]
8. Structural Studies Provide New Insights into the Role of Lysine Acetylation on Substrate Recognition by CARM1 and Inform the Design of Potent Peptidomimetic Inhibitors.
Zhang Y; Marechal N; van Haren MJ; Troffer-Charlier N; Cura V; Cavarelli J; Martin NI
Chembiochem; 2021 Dec; 22(24):3469-3476. PubMed ID: 34569136
[TBL] [Abstract][Full Text] [Related]
9. Venglustat Inhibits Protein N-Terminal Methyltransferase 1 in a Substrate-Competitive Manner.
Dong G; Deng Y; Yasgar A; Yadav R; Talley D; Zakharov AV; Jain S; Rai G; Noinaj N; Simeonov A; Huang R
J Med Chem; 2022 Sep; 65(18):12334-12345. PubMed ID: 36074125
[TBL] [Abstract][Full Text] [Related]
10. A mechanistic study on the inhibition of α-chymotrypsin by a macrocyclic peptidomimetic aldehyde.
Zhang X; Bruning JB; George JH; Abell AD
Org Biomol Chem; 2016 Aug; 14(29):6970-8. PubMed ID: 27349772
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for substrate recognition by the human N-terminal methyltransferase 1.
Dong C; Mao Y; Tempel W; Qin S; Li L; Loppnau P; Huang R; Min J
Genes Dev; 2015 Nov; 29(22):2343-8. PubMed ID: 26543161
[TBL] [Abstract][Full Text] [Related]
12. Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1.
Zhou Q; Wu W; Jia K; Qi G; Sun XS; Li P
Eur J Med Chem; 2022 Dec; 244():114830. PubMed ID: 36228414
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L.
Anglin JL; Deng L; Yao Y; Cai G; Liu Z; Jiang H; Cheng G; Chen P; Dong S; Song Y
J Med Chem; 2012 Sep; 55(18):8066-74. PubMed ID: 22924785
[TBL] [Abstract][Full Text] [Related]
14. Kinetic mechanism of protein N-terminal methyltransferase 1.
Richardson SL; Mao Y; Zhang G; Hanjra P; Peterson DL; Huang R
J Biol Chem; 2015 May; 290(18):11601-10. PubMed ID: 25771539
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Assays of Inhibitors of Methyltransferases.
Cai XC; Kapilashrami K; Luo M
Methods Enzymol; 2016; 574():245-308. PubMed ID: 27423865
[TBL] [Abstract][Full Text] [Related]
16. A stereoselective approach to peptidomimetic BACE1 inhibitors.
Butini S; Gabellieri E; Brindisi M; Giovani S; Maramai S; Kshirsagar G; Guarino E; Brogi S; La Pietra V; Giustiniano M; Marinelli L; Novellino E; Campiani G; Cappelli A; Gemma S
Eur J Med Chem; 2013; 70():233-47. PubMed ID: 24158015
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and molecular modeling studies of derivatives of a highly potent peptidomimetic vinyl ester as falcipain-2 inhibitors.
Ettari R; Micale N; Grazioso G; Bova F; Schirmeister T; Grasso S; Zappalà M
ChemMedChem; 2012 Sep; 7(9):1594-600. PubMed ID: 22753258
[TBL] [Abstract][Full Text] [Related]
18. New substrate analogue furin inhibitors derived from 4-amidinobenzylamide.
Becker GL; Hardes K; Steinmetzer T
Bioorg Med Chem Lett; 2011 Aug; 21(16):4695-7. PubMed ID: 21757345
[TBL] [Abstract][Full Text] [Related]
19. Conformationally Constrained Peptidomimetics as Inhibitors of the Protein Arginine Methyl Transferases.
Knuhtsen A; Legrand B; Van der Poorten O; Amblard M; Martinez J; Ballet S; Kristensen JL; Pedersen DS
Chemistry; 2016 Sep; 22(39):14022-14028. PubMed ID: 27515561
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and molecular simulation study of furoic peptidomimetic derivatives as potent aminopeptodase N inhibitors.
Gao M; He J; Xu W; Lai X; Liu F; Tu G
Pharmazie; 2018 Mar; 73(3):123-127. PubMed ID: 29544557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
